Ads
related to: pharmaceutical company- Request Samples
Get patients started
with a 14-day sample
- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- Co-Pay Program
Resources
to Support Your Patients
- MOA
Mechanism of Action -
Watch A Video To Learn More
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Patient Identification
View a Patient Profile
to Learn More
- Request Samples
Search results
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 6 days agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to...
Insider Monkey via Yahoo Finance· 39 minutes agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 7 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 10 hours agoThis technology can be used in several ways by Novo Nordisk, including the analysis of real-world...
Insider Sale: SVP & CFO Stephen Carey Sells 5,000 Shares of ANI Pharmaceuticals Inc (ANIP)
GuruFocus.com via Yahoo Finance· 2 hours agoOn June 4, 2024, Stephen Carey, Senior Vice President & Chief Financial Officer of ANI ...
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal - Vanda Pharma...
Benzinga· 3 hours agoIn May, Cycle launched its sixth drug product in the U.S. market. In April, Vanda rejected Future Pak LLC’s proposal of $7.25 – $7.75 per share, saying it significantly undervalued the
Vanda Pharmaceuticals stock: why is it up 20% on Thursday?
Invezz· 7 hours agoVanda Pharmaceuticals Inc (NASDAQ: VNDA) is up nearly 20% on Thursday following a report that Cycle ...
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Zacks via Yahoo Finance· 3 hours agoCyclacel Pharmaceuticals (CYCC) might move higher on growing optimism about its earnings prospects,...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 4 hours agoThe company expects total revenues to be more than $575 million in 2024. Revenues in subsequent...
Three ASX Growth Companies With High Insider Ownership And At Least 10% Revenue Growth
Simply Wall St. via Yahoo Finance· 8 minutes agoAmidst a buoyant Australian market where the ASX200 recently closed up by 0.68% with all sectors in...
Ads
related to: pharmaceutical company